As we’ve learned in the global pandemic, the faster we have reliable answers, the better. And as we look to successfully accelerate progress for COVID-19 treatments, the need for collaborative trials that supply reliable insights has never been greater – in many cases, master protocol studies can provide the solution.
Please join us for a public summit, The Fastest Path to Effective COVID-19 Treatments: Using Master Protocol Studies, hosted by CTTI, on Wed., Jan. 13 at 10:30 a.m. EST. The summit, conducted as a webinar and moderated by Pamela Tenaerts, CTTI, will include a welcome from Janet Woodcock, Operation Warp Speed; a call-to-action from Robert M. Califf, Verily and Google Health; remarks from Mark McClellan, Duke-Margolis Center for Health Policy; and a panel discussion moderated by Esther Krofah, FasterCures. The panel will focus on solutions related to scaling master protocols, including:
Overcoming barriers to starting up sites
Increasing participants at existing sites
Using the COVID experience to inform our preparedness for future pandemics
This public summit will also address the status of COVID-19 clinical trials, including results from a recent CTTI analysis of data from ClinicalTrials.gov and other research, and examine the use of common platformsto optimize the design of master protocols for multiple therapies attempting to treat the same diseases or specific health problems.
This public summit is part of a collaborative effort with the Duke-Margolis Center for Health Policy at Duke University and FasterCures, a Center of the Milken Institute.